Home

SpringWorks Therapeutics, Inc. - common stock (SWTX)

51.82
-2.18 (-4.04%)

Springworks Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for underserved patient populations, particularly in the field of rare diseases and oncology

The company utilizes its proprietary drug development platform to identify and advance novel treatments, focusing on precision medicine approaches. By leveraging its expertise in biomarker-driven strategies, Springworks aims to bring transformative therapeutics to market, addressing significant unmet medical needs and improving the quality of life for patients dealing with complex health challenges.

SummaryNewsPress ReleasesChartHistoricalFAQ
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeuticsbenzinga.com
Merck KGaA is in advanced talks to acquire SpringWorks, whose portfolio could bolster Merck's oncology business amid patent expirations and competition.
Via Benzinga · February 11, 2025
Springworks Stock Soars To Nearly 3-Year High On Buyout Buzz, Retail Sentiment Rocketsstocktwits.com
Reuters reported that German healthcare and technology group Merck KGaA is in advanced talks to acquire the company.
Via Stocktwits · February 10, 2025
Crude Oil Rises Sharply; Manhattan Associates Shares Slidebenzinga.com
Via Benzinga · February 10, 2025
Smart Money Is Betting Big In SWTX Optionsbenzinga.com
Via Benzinga · February 10, 2025
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Missbenzinga.com
Via Benzinga · February 10, 2025
Rockwell Automation Posts Upbeat Earnings, Joins Insperity, BP, Alibaba And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · February 10, 2025
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
SpringWorks Therapeutics: Q4 Earnings Insightsbenzinga.com
Via Benzinga · February 27, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · January 27, 2025
SpringWorks Therapeutics Stock Sees RS Rating Jump To 86investors.com
On Monday, SpringWorks Therapeutics stock hit a key technical milestone, seeing its Relative Strength Rating jump to 86.
Via Investor's Business Daily · January 13, 2025
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?benzinga.com
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?
Via Benzinga · January 12, 2025
SpringWorks Therapeutics Stock Gets A RS Rating Liftinvestors.com
The Relative Strength (RS) Rating for SpringWorks Therapeutics stock entered a higher percentile Wednesday, as it got a lift from 62 to 76.
Via Investor's Business Daily · January 8, 2025
Analyst Ratings for SpringWorks Therapeuticsbenzinga.com
Via Benzinga · November 29, 2023
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Ratinginvestors.com
A Relative Strength Rating upgrade for SpringWorks Therapeutics shows improving technical performance.
Via Investor's Business Daily · August 21, 2024
SWTX Stock Earnings: SpringWorks Therapeutics Beats EPS, Beats Revenue for Q2 2024investorplace.com
SWTX stock results show that SpringWorks Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024
SWTX Stock Earnings: SpringWorks Therapeutics Meets EPS, Beats Revenue for Q1 2024investorplace.com
SWTX stock results show that SpringWorks Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024
7 Biotech Stocks to Buy as Sector Rotation Ramps Upinvestorplace.com
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via InvestorPlace · March 13, 2024
Why SpringWorks Therapeutics Stock (SWTX) Is Nosedivingbenzinga.com
SpringWorks Therapeutics Inc (NASDAQSWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing of a publ
Via Benzinga · December 5, 2023
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of Titan Machinery Inc. (NASDAQTITN) moved lower during Thursday’s trading following weak quarterly results.
Via Benzinga · November 30, 2023
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursdaybenzinga.com
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.
Via Benzinga · November 30, 2023
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Shares of SenesTech, Inc. (NASDAQSNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.
Via Benzinga · November 28, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · November 28, 2023
SpringWorks Catapults 24% On A 'Watershed Moment' In Cancer Treatmentinvestors.com
The company gained FDA approval for Ogsiveo, a treatment for desmoid tumors.
Via Investor's Business Daily · November 28, 2023
PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday.
Via Benzinga · November 28, 2023
Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of SpringWorks Therapeutics, Inc. (NASDAQSWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading
Via Benzinga · November 28, 2023